메뉴 건너뛰기




Volumn 46, Issue 24, 2007, Pages 1967-1974

Short-term Effects of Pitavastatin on Biochemical Markers of Bone Turnover in Patients with Hypercholesterolemia

Author keywords

Bone turnover; Hypercholesterolemia; Osteoporosis; Pitavastatin; Statin

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; ENZYME INHIBITOR; PEPTIDE; PITAVASTATIN; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 38749145222     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0419     Document Type: Article
Times cited : (22)

References (33)
  • 1
    • 19744376800 scopus 로고    scopus 로고
    • Anti-oxidative effect of fluvastatin in hyperlipidemic type 2 diabetic patients
    • Miwa S, Watada H, Omura C, et al. Anti-oxidative effect of fluvastatin in hyperlipidemic type 2 diabetic patients. Endocr J 52: 259–264, 2005.
    • (2005) Endocr J , vol.52 , pp. 259-264
    • Miwa, S.1    Watada, H.2    Omura, C.3
  • 2
    • 0042348740 scopus 로고    scopus 로고
    • HMG CoA reductase inhibitors and the skeletal: A comprehensive review
    • Bauer DC. HMG CoA reductase inhibitors and the skeletal: A comprehensive review. Osteoporos Int 14: 273–282, 2003.
    • (2003) Osteoporos Int , vol.14 , pp. 273-282
    • Bauer, D.C.1
  • 3
    • 23744495979 scopus 로고    scopus 로고
    • Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: A meta-analysis
    • Hatzigeorgiou C, Jackson JL. Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: A meta-analysis. Osteoporos Int 16: 990–998, 2005.
    • (2005) Osteoporos Int , vol.16 , pp. 990-998
    • Hatzigeorgiou, C.1    Jackson, J.L.2
  • 4
    • 0033521078 scopus 로고    scopus 로고
    • Stimulation of bone formation in vitro and in rodents by statins
    • Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 286: 1946–1949, 1999.
    • (1999) Science , vol.286 , pp. 1946-1949
    • Mundy, G.1    Garrett, R.2    Harris, S.3
  • 5
    • 0034685669 scopus 로고    scopus 로고
    • Compactin and simvastatin, but not pravastatin, induce bone mor-phogenetic protein-2 in human osteosarcoma cells
    • Sugiyama M, Kodama T, Konishi K, Abe K, Asami S, Oikawa S. Compactin and simvastatin, but not pravastatin, induce bone mor-phogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Commun 271: 688–692, 2000.
    • (2000) Biochem Biophys Res Commun , vol.271 , pp. 688-692
    • Sugiyama, M.1    Kodama, T.2    Konishi, K.3    Abe, K.4    Asami, S.5    Oikawa, S.6
  • 6
    • 0035929257 scopus 로고    scopus 로고
    • Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts
    • Ohnaka K, Shimoda S, Nawata H, et al. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts. Biochem Biophys Res Commun 287: 337–342, 2001.
    • (2001) Biochem Biophys Res Commun , vol.287 , pp. 337-342
    • Ohnaka, K.1    Shimoda, S.2    Nawata, H.3
  • 7
    • 0037214223 scopus 로고    scopus 로고
    • The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity
    • Staal A, Frith JC, French MH, et al. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. J Bone Miner Res 18: 88–96, 2003.
    • (2003) J Bone Miner Res , vol.18 , pp. 88-96
    • Staal, A.1    Frith, J.C.2    French, M.H.3
  • 9
    • 0142227255 scopus 로고    scopus 로고
    • Effect of pretreatment vitamin D levels on in vivo effects of atorvastatin on bone metabolism in patients with heterozygous familial hypercholesterolemia
    • Kajinami K, Takekoshi N, Matsui S, et al. Effect of pretreatment vitamin D levels on in vivo effects of atorvastatin on bone metabolism in patients with heterozygous familial hypercholesterolemia. Am J Cardiol 92: 1113–1116, 2003.
    • (2003) Am J Cardiol , vol.92 , pp. 1113-1116
    • Kajinami, K.1    Takekoshi, N.2    Matsui, S.3
  • 10
    • 0242408377 scopus 로고    scopus 로고
    • Atorvastatin, 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces bone resorption in the elderly
    • Kuzuya M, Suzuki Y, Asai T, et al. Atorvastatin, 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces bone resorption in the elderly. J Am Geriatr Soc 51: 1677–1678, 2003.
    • (2003) J Am Geriatr Soc , vol.51 , pp. 1677-1678
    • Kuzuya, M.1    Suzuki, Y.2    Asai, T.3
  • 11
    • 3042634621 scopus 로고    scopus 로고
    • Age-dependent effects of atorvastatin on biochemical bone turnover markers: A randomized controlled trial in postmenopausal women
    • Berthold HK, Unverdorben S, Zittermann A, et al. Age-dependent effects of atorvastatin on biochemical bone turnover markers: A randomized controlled trial in postmenopausal women. Osteoporos Int 15: 459–467, 2004.
    • (2004) Osteoporos Int , vol.15 , pp. 459-467
    • Berthold, H.K.1    Unverdorben, S.2    Zittermann, A.3
  • 12
    • 4344674934 scopus 로고    scopus 로고
    • The effect of atorvastatin on markers of bone turnover in patients with type 2 diabetes
    • Braatvedt GD, Bagg W, Gamble G, Davidson J, Reid IR. The effect of atorvastatin on markers of bone turnover in patients with type 2 diabetes. Bone 35: 766–770, 2004.
    • (2004) Bone , vol.35 , pp. 766-770
    • Braatvedt, G.D.1    Bagg, W.2    Gamble, G.3    Davidson, J.4    Reid, I.R.5
  • 13
    • 0034957690 scopus 로고    scopus 로고
    • The effect of fluvastatin on parameters of bone remodeling
    • Bjarnason NH, Riis BJ, Christiansen C. The effect of fluvastatin on parameters of bone remodeling. Osteoporos Int 12: 380–384, 2001.
    • (2001) Osteoporos Int , vol.12 , pp. 380-384
    • Bjarnason, N.H.1    Riis, B.J.2    Christiansen, C.3
  • 15
    • 3242799093 scopus 로고    scopus 로고
    • Effects of simvastatin on bone turnover and BMD: A 1-year randomized controlled trial in postmenopausal osteopenic women
    • Rejnmark L, Buus NH, Vestergaard P, et al. Effects of simvastatin on bone turnover and BMD: A 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res 19: 737–744, 2004.
    • (2004) J Bone Miner Res , vol.19 , pp. 737-744
    • Rejnmark, L.1    Buus, N.H.2    Vestergaard, P.3
  • 18
    • 33947602882 scopus 로고    scopus 로고
    • Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia
    • Majima T, Komatsu Y, Fukao A, Ninomiya K, Matsumura T, Nakao K. Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia. Endocr J 54: 145–151, 2007.
    • (2007) Endocr J , vol.54 , pp. 145-151
    • Majima, T.1    Komatsu, Y.2    Fukao, A.3    Ninomiya, K.4    Matsumura, T.5    Nakao, K.6
  • 21
    • 0034626389 scopus 로고    scopus 로고
    • Lack of positive correlation between statin use and bone mineral density in Japanese subjects with type 2 diabetes
    • Wada Y, Nakamura Y, Koshiyama H. Lack of positive correlation between statin use and bone mineral density in Japanese subjects with type 2 diabetes. Arch Intern Med 160: 2865–2870, 2000.
    • (2000) Arch Intern Med , vol.160 , pp. 2865-2870
    • Wada, Y.1    Nakamura, Y.2    Koshiyama, H.3
  • 22
    • 0036063969 scopus 로고    scopus 로고
    • Relation of statin use and bone loss: A prospective population-based cohort study in early postmenopausal women
    • Sirola J, Honkanen R, Kroger H, Jurvelin JS, Maenpaa P, Saarik-oski S. Relation of statin use and bone loss: A prospective population-based cohort study in early postmenopausal women. Osteoporos Int 13: 537–541, 2002.
    • (2002) Osteoporos Int , vol.13 , pp. 537-541
    • Sirola, J.1    Honkanen, R.2    Kroger, H.3    Jurvelin, J.S.4    Maenpaa, P.5    Saarik-oski, S.6
  • 23
    • 0037318567 scopus 로고    scopus 로고
    • Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation
    • Maeda T, Kawane T, Horiuchi N. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. Endocrinology 144: 681–692, 2003.
    • (2003) Endocrinology , vol.144 , pp. 681-692
    • Maeda, T.1    Kawane, T.2    Horiuchi, N.3
  • 24
    • 0141988934 scopus 로고    scopus 로고
    • Pitavastatin efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor
    • Kajinami K, Takekoshi N, Saito Y. Pitavastatin efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor. Cardiovasc Drug Rev 21: 199–215, 2003.
    • (2003) Cardiovasc Drug Rev , vol.21 , pp. 199-215
    • Kajinami, K.1    Takekoshi, N.2    Saito, Y.3
  • 25
    • 1642341604 scopus 로고    scopus 로고
    • Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation
    • Oxlund H, Andreassen TT. Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation. Bone 34: 609–618, 2004.
    • (2004) Bone , vol.34 , pp. 609-618
    • Oxlund, H.1    Andreassen, T.T.2
  • 26
    • 0034765171 scopus 로고    scopus 로고
    • Changes in bone biochemical markers after high-dose cerivastatin treatment in a woman with osteogenesis imperfecta
    • Sugiyama T, Kawai S. Changes in bone biochemical markers after high-dose cerivastatin treatment in a woman with osteogenesis imperfecta. J Bone Miner Metab 19: 382–384, 2001.
    • (2001) J Bone Miner Metab , vol.19 , pp. 382-384
    • Sugiyama, T.1    Kawai, S.2
  • 27
    • 0344877301 scopus 로고    scopus 로고
    • Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: Results from a randomized placebo-controlled trial
    • Morii H, Ohashi Y, Taketani Y, et al. Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: Results from a randomized placebo-controlled trial. Osteoporos Int 14: 793–800, 2003.
    • (2003) Osteoporos Int , vol.14 , pp. 793-800
    • Morii, H.1    Ohashi, Y.2    Taketani, Y.3
  • 28
    • 0023690733 scopus 로고
    • Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease
    • Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S. Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ 297: 960–963, 1988.
    • (1988) BMJ , vol.297 , pp. 960-963
    • Lind, L.1    Jakobsson, S.2    Lithell, H.3    Wengle, B.4    Ljunghall, S.5
  • 29
    • 0031698795 scopus 로고    scopus 로고
    • Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EP1DOS prospective study
    • Garnero P, Dargent-Molina P, Hans D, et al. Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EP1DOS prospective study. Osteoporos Int 8: 563–569, 1998.
    • (1998) Osteoporos Int , vol.8 , pp. 563-569
    • Garnero, P.1    Dargent-Molina, P.2    Hans, D.3
  • 30
    • 18044393805 scopus 로고    scopus 로고
    • Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alen-dronate in postmenopausal Japanese women with osteoporosis
    • Iwamoto J, Takeda T, Sato Y, Uzawa M. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alen-dronate in postmenopausal Japanese women with osteoporosis. J Bone Miner Metab 23: 238–242, 2005.
    • (2005) J Bone Miner Metab , vol.23 , pp. 238-242
    • Iwamoto, J.1    Takeda, T.2    Sato, Y.3    Uzawa, M.4
  • 31
    • 0034921518 scopus 로고    scopus 로고
    • Hypercholesterolemia as a possible risk factor for osteopenia in type 2 diabetes mellitus
    • Koshiyama H, Wada Y, Nakamura Y. Hypercholesterolemia as a possible risk factor for osteopenia in type 2 diabetes mellitus. Arch Intern Med 161: 1678, 2001.
    • (2001) Arch Intern Med , vol.161 , pp. 1678
    • Koshiyama, H.1    Wada, Y.2    Nakamura, Y.3
  • 32
    • 23744489123 scopus 로고    scopus 로고
    • Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients
    • Majima T, Komatsu Y, Yamada T, et al. Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients. Osteoporos Int 16: 907–913, 2005.
    • (2005) Osteoporos Int , vol.16 , pp. 907-913
    • Majima, T.1    Komatsu, Y.2    Yamada, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.